Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
JNJ-89853413 for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Toronto, Ontario
"This trial aims to determine the safe and recommended dose for Phase 2 of a new treatment for patients with relapsed or refractory acute myeloid leukemia (AML) or higher-risk myelod
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service